4//SEC Filing
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. 4
Accession 0001140361-25-023976
CIK 0000275053other
Filed
Jun 26, 8:00 PM ET
Accepted
Jun 27, 4:27 PM ET
Size
7.7 KB
Accession
0001140361-25-023976
Insider Transaction Report
Form 4
Transactions
- Sale
Common Stock
2025-06-27$11.46/sh−2,854,607$32,713,796→ 0 total(indirect: by Fosun Pharma USA Inc.)
Holdings
- 64,167(indirect: by Fosun Industrial Co., Limited)
Common Stock
Fosun Pharma USA Inc.
10% Owner
Transactions
- Sale
Common Stock
2025-06-27$11.46/sh−2,854,607$32,713,796→ 0 total(indirect: by Fosun Pharma USA Inc.)
Holdings
- 64,167(indirect: by Fosun Industrial Co., Limited)
Common Stock
Footnotes (3)
- [F1]The shares were sold pursuant to that certain Underwriting Agreement. dated June 25, 2025, among Fosun Pharma USA Inc., the Issuer, and the underwriter party thereto.
- [F2]Fosun Pharma USA Inc. is a wholly-owned subsidiary of Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
- [F3]Fosun Industrial Co., Limited is a wholly-owned subsidiary of Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
Documents
Issuer
NATURES SUNSHINE PRODUCTS INC
CIK 0000275053
Entity typeother
IncorporatedChina
Related Parties
1- filerCIK 0001615258
Filing Metadata
- Form type
- 4
- Filed
- Jun 26, 8:00 PM ET
- Accepted
- Jun 27, 4:27 PM ET
- Size
- 7.7 KB